Detalhe da pesquisa
1.
Activation of the Calcium Receptor by Calcimimetic Agents Is Preserved Despite Modest Attenuating Effects of Hyperphosphatemia.
J Am Soc Nephrol
; 33(1): 201-212, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34732508
2.
Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism.
Calcif Tissue Int
; 101(6): 641-653, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29038882
3.
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
Circulation
; 132(1): 27-39, 2015 Jul 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26059012
4.
Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
J Am Soc Nephrol
; 26(6): 1466-75, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25505257
5.
Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism.
Kidney Int
; 87(4): 846-56, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25337774
6.
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
N Engl J Med
; 367(26): 2482-94, 2012 Dec 27.
Artigo
Inglês
| MEDLINE | ID: mdl-23121374
7.
The Use of Calcimimetics for the Treatment of Secondary Hyperparathyroidism: A 10 Year Evidence Review.
Semin Dial
; 28(5): 497-507, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25752650
8.
Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study.
Nephrol Dial Transplant
; 28(1): 146-52, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23028103
9.
Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis.
BMC Nephrol
; 14: 88, 2013 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-23594621
10.
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial.
Nephrol Dial Transplant
; 27(7): 2872-9, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22529163
11.
Calcimimetic use in US hemodialysis facilities in first 2 years after the launch of etelcalcetide: A descriptive analysis of real-world clinical practice and outcomes.
Hemodial Int
; 26(2): 243-254, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34931443
12.
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis.
Nephrol Dial Transplant
; 26(4): 1327-39, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21148030
13.
The association of vitamin D use with hypercalcemia and hyperphosphatemia in hemodialysis patients: a case-crossover study.
Pharmacoepidemiol Drug Saf
; 20(9): 914-21, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21735509
14.
Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients.
Nephrol Dial Transplant
; 25(6): 1916-23, 2010 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-20110249
15.
Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics.
Kidney Int
; 74(3): 276-88, 2008 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-17568787
16.
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
N Engl J Med
; 350(15): 1516-25, 2004 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-15071126
17.
Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.
Hemodial Int
; 20(3): 421-31, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26564024
18.
Calcium and phosphorus metabolism in patients who have chronic kidney disease.
Med Clin North Am
; 89(3): 631-47, 2005 May.
Artigo
Inglês
| MEDLINE | ID: mdl-15755471
19.
Cardiovascular and Renal Outcomes Trials-Is There a Difference?
Am J Cardiol
; 116(6): 982-8, 2015 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26198118
20.
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
Clin J Am Soc Nephrol
; 10(5): 791-9, 2015 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-25710802